Aug 13, 2026
Market Forecast
The chemical gas sterilizers market was valued at USD 1.31 billion in 2025 and is projected to grow from USD 1.369 billion in 2026 to USD 1.875 billion by 2033, at a CAGR of 4.60% through the forecast period, according to a new report by Transpire Insights.
Stringent sterility assurance requirements for medical devices and pharmaceutical products, expanding healthcare infrastructure in emerging markets, and regulatory scrutiny driving transitions away from legacy sterilization chemistries are the central forces behind this market. Chemical gas sterilization remains the required method for heat-sensitive and moisture-sensitive products that cannot be processed through steam autoclave or radiation sterilization — a category that encompasses a large and growing proportion of modern medical device designs.
Chemical Gas Sterilizers Market Growth & Trends
The medical device industry's continued shift toward single-use devices, minimally invasive surgical instruments, and complex polymer-based implantables is increasing the volume of products that require low-temperature sterilization methods. Ethylene oxide has been the dominant chemistry for heat-sensitive device sterilization for decades, and while regulatory pressure on EO emissions is intensifying, the absence of equally capable alternatives for many device types means EO remains the method of choice for a large installed base of medical device products in the near term.
Pharmaceutical sterility testing and contamination control requirements are also driving sterilizer equipment demand, particularly in biologics manufacturing facilities where sterility assurance across process equipment and transfer materials must be demonstrated to regulatory bodies. The growth of contract pharmaceutical manufacturing — particularly in Asia — is creating new facility build-out and equipment commissioning activity that generates sterilizer procurement alongside other clean room and contamination control equipment.
Emerging Economies & Technology
Asia Pacific is a major growth region for chemical gas sterilizer procurement, driven by expanding hospital infrastructure in China, India, and Southeast Asia, and by the rapid growth of medical device manufacturing in these markets for both domestic use and export. Indian medical device manufacturers seeking FDA and CE mark approval for export products must implement validated sterilization processes that meet international standards — creating demand for internationally approved sterilization equipment and service infrastructure.
Hydrogen peroxide vapour sterilization is the technology area attracting the most significant development investment, driven by the regulatory environment around ethylene oxide emissions in the United States and Europe. The EPA's ongoing review of EO emission limits at commercial sterilization facilities has created urgency around alternative technology qualification for device types where validated alternatives can be demonstrated. Suppliers including Advanced Sterilization Products, STERIS, and Getinge are all investing in expanded hydrogen peroxide sterilization capacity and device biocompatibility validation work to capture the transition demand.
Ethylene Oxide Sterilizers Segment
Ethylene oxide sterilization systems hold 37% of the chemical gas sterilizers market — the largest segment by revenue. Despite regulatory headwinds around emissions, EO retains its dominant position because of its unmatched material compatibility, deep penetration capability, and the breadth of validated device types for which no alternative method has yet been qualified. Revalidating a sterilization process for a medical device on a new chemistry requires significant time, cost, and regulatory documentation — creating a high switching cost that keeps EO in position for the majority of the current installed base.
EO sterilizer manufacturers are investing in emission abatement technology to help existing and new users comply with tightening air quality regulations while maintaining the process chemistry that their device validation packages depend upon. Catalytic oxidation systems, emissions monitoring, and process optimisation to reduce cycle gas concentrations are all being incorporated into next-generation EO sterilizer designs that address the environmental concerns without requiring device revalidation.
Hydrogen Peroxide Sterilizers: Fastest-Growing Segment
Hydrogen peroxide sterilization systems are growing at a CAGR of 8.6% — the fastest rate in the chemical gas sterilizers market. The combination of regulatory pressure on EO, the proven efficacy of hydrogen peroxide vapour against a broad microbial spectrum, and the absence of toxic residues on processed materials is driving both new facility specification of H2O2 systems and active evaluation of H2O2 as an EO alternative for specific device types. Point-of-care sterilization in hospital settings — where centralised EO processing is impractical — is a well-established H2O2 application that continues to grow with healthcare infrastructure expansion.
The development of new sterilization cycle parameters validated for larger and more complex device geometries is progressively expanding the range of products for which H2O2 sterilization is a technically viable alternative to EO. As this validated device portfolio broadens, the business case for transitioning new device launches to H2O2 sterilization strengthens, creating a long-term demand trajectory that will extend well beyond the current regulatory push.
Europe – Largest Regional Market
Europe holds 39% of the chemical gas sterilizers market — the largest regional share. The EU Medical Device Regulation and In Vitro Diagnostic Regulation have driven significant investment in sterilization process validation and documentation across European medical device manufacturers. European healthcare systems also operate a large base of hospital sterilization departments processing reusable surgical instruments, with hydrogen peroxide and formaldehyde sterilizers handling device types unsuitable for steam processing.
STERIS, Getinge, Belimed, and Matachana all have significant European manufacturing and service infrastructure, giving them strong service coverage for the large installed equipment base across European hospitals, clinics, and pharmaceutical facilities. The European market's regulatory sophistication and procurement professionalism also means that technical capability, validation support, and lifecycle service quality carry significant weight in equipment selection decisions.
North America – Fastest-Growing Region
North America is advancing at a CAGR of 9.9% — the highest regional rate in this market. The US market is being shaped by the EPA's National Emission Standards for Hazardous Air Pollutants review of commercial and in-house EO sterilization facilities, which is creating investment in emissions control technology at existing EO operations and accelerating evaluation of alternative sterilization technologies for new facilities and device types. This regulatory dynamic is generating both equipment upgrade demand and new system procurement activity.
Contract sterilization companies operating large commercial EO facilities in the US — which process medical devices for hundreds of manufacturers — are making significant capital investments in emission abatement systems to maintain operating permits while managing the compliance transition. These investments are substantial revenue events for EO equipment and emissions control system suppliers, and they are concentrated in the US market where regulatory enforcement timelines are most defined.
What Are the Recent Developments in the Chemical Gas Sterilizers Market?
Q4 2024 – STERIS: Launched an updated generation of its VHP sterilization system with expanded chamber capacity and a new cycle development software package targeting medical device manufacturers qualifying hydrogen peroxide sterilization for existing EO-validated product lines.
Q4 2024 – Advanced Sterilization Products: Received FDA clearance for an expanded list of compatible device types for its STERRAD sterilization system, including several new polymer compositions and complex lumen geometries that were previously validated only for EO processing.
Q1 2025 – Getinge: Commissioned a new manufacturing facility in India for chemical gas sterilization equipment, targeting the growing Indian medical device and pharmaceutical manufacturing market with locally produced systems supported by domestic service infrastructure.
Q2 2025 – 3M: Introduced an enhanced biological indicator system for monitoring hydrogen peroxide sterilization cycle efficacy, providing faster result readout and digital cycle record integration for hospital sterile processing department compliance documentation.
Q2 2025 – Noxilizer: Signed a technology licensing agreement with a contract sterilization operator to scale nitrogen dioxide sterilization capacity at two US commercial sterilization facilities, targeting medical devices for which both EO and H2O2 present technical compatibility challenges.
Q3 2025 – Belimed: Launched an upgraded ethylene oxide sterilizer platform incorporating integrated catalytic emission abatement technology, enabling hospital and device manufacturer in-house sterilization operations to meet tightening EPA and European air quality emission limits without separate abatement system installation.
About Transpire Insight
Turning Complex Data into Clear, Actionable Market Intelligence
In today’s hyper-competitive and fast-moving economy, guessing isn’t a business strategy. To lead your industry, launch game-changing products, or scale into new geographies, you need precise, reliable market intelligence, not just high-level noise.
At Transpire Insight, we are a full-service market research, data analytics, and strategic consulting firm. We help corporate leaders, innovators, and investors navigate complex market shifts with absolute confidence.
By combining rigorous primary research, deep statistical modeling, and hands-on domain expertise, we convert raw data into high-impact strategic roadmaps that drive measurable growth.
What Drives Us
Markets don’t stand still, and neither do we. Our core mission is simple: to empower organizations with verified, technology-enabled insights that remove guesswork from strategic planning.
Whether you are evaluating a niche technological shift, assessing supply chain dynamics, or looking for high-growth target segments, our intelligence gives you a decisive competitive edge.
Why Leading Enterprises Trust Transpire Insight
We don't offer one-size-fits-all research. Our analysts specialize in dedicated verticals—from Biotechnology and Semiconductors to Advanced Automotive, Clean Energy, and Industrial Manufacturing. We speak your industry's language and understand the specific nuances, regulatory shifts, and economic drivers shaping your market.
Syndicated Market Reports: In-depth, turn-key research studies covering market size, share, competitive benchmarking, and multi-year forecasts.
Customized Market Intelligence: Tailored research engagements built around your exact business questions, specific product lines, or targeted regional dynamics.
Strategic Consulting: On-demand analytical support, entry-strategy planning, and direct consultation to help you act on data with speed and accuracy.
Reliable forecasts demand ground-truth data. Our research process combines comprehensive desk research with extensive primary interviews across key industry stakeholders including C-suite executives, supply chain leaders, procurement heads, and subject matter experts. Every report undergoes strict validation to ensure maximum precision and relevance.
Our Core Sectors
We provide continuous tracking and deep-dive analytical coverage across high-impact industries:
Manufacturing and Construction
Let’s Shape Your Growth Strategy Together
Whether you are preparing for your next fiscal cycle, analyzing market entry barriers, or looking for deep-dive quantitative data, Transpire Insight is your trusted intelligence partner.
Ready to gain a clearer view of your market?
Email Us: [email protected]
Speak to Our Analyst: +91 7666513636
Want to dive deeper? Head over to www.transpireinsight.com or join our community on Twitter, LinkedIn, and Facebook for the latest updates